➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
Dow
AstraZeneca
Express Scripts

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ACALABRUTINIB


Email this page to a colleague

« Back to Dashboard

ACALABRUTINIB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Astrazeneca CALQUENCE acalabrutinib CAPSULE;ORAL 210259 NDA AstraZeneca Pharmaceuticals LP 0310-0512-60 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0310-0512-60) 2017-10-31
Astrazeneca CALQUENCE acalabrutinib CAPSULE;ORAL 210259 NDA AstraZeneca Pharmaceuticals LP 0310-0512-95 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0310-0512-95) 2017-10-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Baxter
Boehringer Ingelheim
Harvard Business School
Moodys